IHE Publications
- Cancer
- Chronic Diseases / Disorders
- Diabetes
- Diagnosis
- Fetal Alcohol Spectrum Disorder (FASD)
- Health Economics / Healthcare Costs
- Health Measurement Tools
- Health Policy
- Healthcare Services
- Infectious Diseases
- Maternal and Child Health
- Mental Health
- Other
- Pharmaceuticals
- Prevention
- Quality of Life
- Screening
- Surveillance
- Telehealth
- Therapy
- Brown, Jasmine
- Chojecki, Dagmara
- Corabian, Paula
- Escober-Doran, Carissa
- Guo, Bing
- Harstall, Christa
- Husereau, Don
- Institute of Health Economics, IHE
- Jacobs, Philip
- Jonsson, Egon
- Moga, Carmen
- Nguyen, Thanh
- Ohinmaa, Arto
- Scott, Ann
- Sproule, John
- Thompson, Angus
- Tjosvold, Lisa
- Waye, Arianna
- Yan, Charles
- Zheng, Yufei
Towards a framework for biosimilar evidence and knowledge exchange: Summary report of the IHE Biosimilars Forum
This report provides a summary of the IHE Biosimilars Forum engagement exercise that took place on April 23, 2017 in Ottawa, Ontario. The intent of the forum was to identify: options to categorize and consider biosimilars; a process to engage stakeholders to identify place in therapy and further evidence development that may be required; and an approach to knowledge exchange that will enable a common view and shared agreement amongst stakeholders regarding appropriate and intended use of biosimilars.
Event Link: IHE Biosimilars Invitational Forum
Publication Type: Summary Reports
Year of Publication: 2017
Topics: Pharmaceuticals, Therapy
Authors: IHE Institute of Health Economics
ISBN (online): 978-1-926929-83-5